[56] This biochemical cascade increases mitochondrial thermogenesis, effectively forcing the body to dissipate excess calories as heat and increasing overall energy expenditure
Included in the core analysis were 1822 patients treated with a GLP-1 RA and 992 individuals treated with an SGLT2i
Though the medication was originally developed as a diabetes drug, its been shown to be effective for a myriad of conditions, like polycystic ovarian syndrome and migraines
More recently, GLP-1 RA drugs have been approved for weight loss, cardiovascular disease, and chronic kidney disease
Why is compounded semaglutide no longer available, and how does this affect patients who used it
Eli Lilly is expected to submit for FDA approval in late 2026, with potential U.S